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Review
In Singapore, rare blood donors are those whose red 
blood cells (RBCs) lack a high-prevalence antigen or lack a 
combination of common antigens that can only be found in 1 
in 1000 or fewer blood donors (Table 1).
The Health Sciences Authority’s Blood Services Group 
(BSG) is the national blood service in Singapore. The BSG has 
been maintaining a registry of donors with rare blood types 
since 2004. RBC units from these donors are cryopreserved 
using the high-concentration (40%) glycerol method and a 
slow freezing rate. Frozen rare donor RBC units are stored at 
–65°C or lower in mechanical freezers and are kept for up to 
10 years.
With more patients receiving blood transfusions for 
complex surgeries and undergoing aggressive treatments 
for hematological diseases (chemotherapy, bone marrow 
transplant, etc.) in Singapore, our national Red Cell Serology 
Reference Laboratory started to notice an increase in the num-
ber of multiple RBC alloantibodies in transfusion recipients 
and the appearance of RBC antibodies not previously seen in 
Singapore (e.g., anti-k).
Since 2011, BSG has been maintaining a regular inventory 
of non-cryopreserved phenotyped blood to ensure that 
antigen-negative RBC units are readily available for patients 
because the thawing and deglycerolization process of frozen 
blood units takes several hours. This inventory includes Fy(a−), 
Fy(b−), Jk(a−), Jk(b−), S−, and s− RBC units, as well as units 
with multiple common antigen–negative combinations such 
as R1R1 Fy(a−) or Fy(b−); R2R2 s−; or R1R1 Jk(a−) or Jk(b−), 
and s−.
The Singapore Rare Donor Program aims to meet the 
rare blood requirements of patients in Singapore through 
appropriate targeted screening among the regular voluntary 
blood donors. An example of this initiative was the mass 
screening of blood donors in 2013 using the urea lysis test 
on the Olympus PK7300 as a rapid screening for Jk(a–b–) 
donors after having to supply blood for a surgical patient with 
alloantibody to Jk3. We were able to identify an additional 10 
donors, all confirmed to be Jk(a−b−) by serology. Our study 
also showed that the prevalence of Jk(a–b–) phenotype was 1 
in 3600 in the Singapore donor population.
If rare blood cannot be found among our donor population, 
we first discuss with the clinician if autologous transfusion 
is possible. If not, we screen the patient’s immediate family 
members (siblings and parents) to look for the rare blood 
phenotype. We apply similar stringent selection criteria as 
for any other blood donor before accepting blood donations 
from these family members. In 2014, we had to supply blood 
for a neonate with hemolytic disease of the fetus and newborn 
caused by anti-Hr0. Because of the urgency of the transfusion 
requirement and ABO incompatibility with the mother, we 
screened the mother’s siblings and found one of them to be 
negative for Hr0; this individual became a regular voluntary 
blood donor.
Because knowledge of the distribution of blood groups 
present in our donor population can help in the identification 
of rare phenotypes, we are presently revising our screening 
strategies using our local antigen prevalence data to make the 
screening process for rare blood types more efficient. We are 
also in discussion with the Singapore Red Cross to design a 
program for maintaining our existing rare blood donors and 
recruiting new blood donors. Under a unique partnership with 
BSG, the Singapore Red Cross is responsible for the national 
blood donor recruitment and retention program.
BSG follows a policy of voluntary non-remunerated blood 
donation, and rare blood donors are managed in the same way 
as the rest of the blood donors, with no material rewards or 
incentives. However, they are informed that they will be given 
priority access to the rare blood inventory in the event that 
they need blood themselves.
Currently, we have 37 active donors that meet our 
definition of a rare blood donor, and we have included them 
in our rare blood donor registry (Table 1). From these donors, 
we were able to collect 43 RBC units, which are currently in 
our frozen inventory. Between 2012 and 2014, there were three 
cases (liver transplant, lung resection, and placenta previa) of 
patients in Singapore requiring rare blood, and these patients 
were fully supported. Besides screening for donors of rare 
blood required locally, we also hope to find some donors of 
other rare blood types encountered in other Asian countries 
[Rhnull, Di(b−), etc.]. We have not transfused incompatible 
blood to recipients requiring antigen-negative RBC units.
Rare donor units collected and kept in frozen inventory 
starting from 2006 follow the International Society of Blood 
Transfusion (ISBT) 128 standard for labeling, which is the 
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global standard for the identification, labeling, and information 
transfer of human blood, cell, tissue, and organ products across 
international borders and disparate health care systems. This 
system will facilitate international shipping of blood products 
available in Singapore to other countries if there is a request for 
rare blood units, although BSG has not imported or received a 
request from other countries or blood centers to provide rare 
donor units in recent years.
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Table 1. Donor and cryopreserved unit information for blood types 









H– (Oh) 4 5
Hr0– (D−−) 1 2
Multiple antigen-negative combinations
R1R1, Jk(a−) or Jk(b−), Fy(a−) or Fy(b−), and s− 0 0
R2R2, Jk(a−) or Jk(b−), Fy(a−) or Fy(b−), and s− 0 0
R2R2, Fy(a−), s− 0 0
rr, Jk(a−) or Jk(b−), Fy(a−) or Fy(b−), and s− 0 0
r˝r˝, Fy(a−), or s− 0 0
